Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (5,167,520) $ (3,043,399)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 33,174 26,978
Stock-based compensation expense 131,579 137,358
Change in fair value of derivative liability (3) (43,655)
Amortization of debt discount 0 154,836
Loss from divestiture of asset 307,086 0
Debt conversion inducement expense 1,383,285 0
Accrued interest conversion expense (15,952) 0
Foreign currency remeasurement gain (45,351) 0
Changes in assets and liabilities:    
Prepaid expenses 96,668 7,213
Prepaid expenses - related party 0 (35,476)
Other current assets (258,443) (52,880)
Accounts payable (445,903) (19,160)
Accounts payable - related parties (20,331) 21,896
Accrued interest - related party 0 43,128
Accrued payroll liabilities 134,767 (107,413)
Operating lease liability 2,618 (19,565)
Other current liabilities (132,651) 15,264
Other current liabilities - related parties (95,850) 0
Net cash used in operating activities (4,060,923) (2,914,875)
Cash flows from investing activities:    
Proceeds from asset sale, net of legal expenses 5,532,266 0
Purchase of property and equipment (1,860) (1,999)
Net cash provided by (used in) investing activities 5,530,406 (1,999)
Cash flows from financing activities:    
Repayment of insurance premium loan payable (45,307) (61,230)
Net cash used in financing activities (45,307) (59,263)
Net increase (decrease) in cash and restricted cash 1,424,176 (2,976,137)
Cash, cash equivalents and restricted cash, beginning of period 1,249,107 8,987,578
Cash, cash equivalents and restricted cash, end of period 2,673,283 6,011,441
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 2,668,697 6,006,869
Restricted cash 4,586 4,572
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 2,673,283 6,011,441
Cash paid during the period for:    
Interest 4,275 0
Income taxes 5,141 0
Supplemental disclosures of non-cash financing activities:    
Common stock warrant exercises 282,905 0
Conversion of multi-draw credit agreement 1,565,470 0
Conversion of accrued interest due to related party 31,766 0
Financing of insurance premium 203,884 275,537
Release of share liability to additional paid-in-capital 0 13,000
Prefunded Warrants    
Cash flows from financing activities:    
Proceeds from pre-funded warrant exercises $ 0 $ 1,967